- Tytuł:
- Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial
- Autorzy:
- Źródło:
- Breast Cancer Research and Treatment. 174(2):433-442
Czasopismo naukowe